- Home
- ALT vs CHW Comparison
ALT vs CHW Comparison
Compare ALT & CHW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALT | CHW |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 573.8M | 527.5M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ALT | CHW |
|---|---|---|
| Price | $2.17 | $7.79 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $17.11 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 217.9K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.17 | $6.98 |
| 52 Week High | $6.44 | $9.18 |
Technical Indicators
Market Signals| Indicator | ALT | CHW |
|---|---|---|
| Relative Strength Index (RSI) | 24.16 | 33.72 |
| Support Level | N/A | $7.65 |
| Resistance Level | $3.09 | $8.26 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 0.84 | 11.93 |
Price Performance
Historical ComparisonAbout ALT Altimmune Inc.
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About CHW Calamos Global Dynamic Income Fund
Calamos Global Dynamic Income Fund operates as a closed-end management investment company. The company's investment objective is to generate a high level of current income with the objective of capital appreciation. It dynamically allocates its investment among equities, convertible bonds, fixed-income securities, and alternative investments.